It has been demonstrated that intravirion reverse transcription in human immunodeficiency virus type I (HIV-1) occurs in the presence of physiological substances and that the intravirion HIV-1 reverse transcripts are important for the establishment of infection in nondividing cells. In this report, we demonstrate that the infectivity of the virus produced from replicating peripheral blood lymphocytes (PBL) is significantly higher than that of virions produced by nonproliferating macrophages, upon infection of either initially quiescent PBLs or macrophages. This directly correlated with significantly higher intravirion reverse transcripts in the virions from replicating PBLs, compared to those from macrophages. Treatment of replicating PBLs and macrophages with 3Ј-azido-3Ј-deoxythymidine resulted in decreased intravirion reverse transcripts and lower infectivity of produced virions, upon infection of initially quiescent T-cells or macrophages. Because both nonproliferating macrophages and replicating lymphocytes are the major reservoirs for HIV-1 in vivo, we propose that as the result of higher levels of intravirion reverse transcripts, the HIV-1 virions produced from actively replicating cells are more infectious than those from nonproliferating cells. As such, this scenario implies at least one molecular mechanism for the intra-and interhost transmission of HIV-1.
INTRODUCTION
Endogenous reverse transcription (RT) reactions are important in evaluation of the kinetics and molecular intermediates of reverse transcription in various retroviruses (Yong et al., 1990; Fuetterer and Hohn, 1987; Baboonian et al., 1991) . Reverse transcription of retroviruses can occur within cell-free virions rather than only after infection of target cells (Zhang et al., 1993 (Zhang et al., , 1994 (Zhang et al., , 1995a Lori et al., 1992; Trono, 1992) . Several studies have demonstrated that a significant level of endogenous RT activity is found in human immunodeficiency virus type I (HIV-1) without permeabilization (Zhang et al., 1993; Zhang et al., 1996a,b,c) . Earlier, we reported that deoxyribonucleoside triphosphates (dNTPs) enter into HIV-1 virions, without exogenous permeabilization of the viral envelope, and DNA synthesis occurs to full-length or nearly full-length (Zhang et al., 1996a) . Similar results were obtained if murine leukemia virus was treated with high concentrations of dNTPs (Zhang et al., 1995a) .
Intravirion HIV-1 DNA synthesis could occur in the presence of several human physiological fluids, including seminal and blood plasma. This phenomenon may be due to endogenous dNTPs or physiological polyamines within these fluids. Intravirion HIV-1 DNA, which was increased by higher concentrations of dNTPs, also increased viral infectivity in initially quiescent primary human T-lymphocytes but not in replicating T-lymphocytic cell lines (Zhang et al., 1996a) . We reported that amphipathic domains in the C-terminus of HIV-1 gp41 may transverse the viral envelope leading to increased permeabilization to dNTPs and polyamines (Zhang et al., 1996c) .
Of note, HIV-1 RT efficiency in primary human macrophages is significantly slower than in T-lymphoid cell lines (O'Brien et al., 1994; Collin and Gordon, 1994) . In these important studies, the investigators demonstrated, by using quantitative polymerase chain reaction (PCR) , that production of HIV-1 cDNA structures in macrophages required more than 36 h for full-length viral DNA synthesis, whereas H9 T-lymphocytic cells could complete reverse transcription in 6-16 h after infection (O'Brien et al., 1994; Collin and Gordon, 1994) . This is thought to be due to low levels of free dNTPs in the cytoplasm of macrophages (O'Brien et al., 1994; Meyerhans et al., 1994) . Interestingly, hydroxyurea, which lowers intracellular dNTP levels, has also been demonstrated to inhibit HIV-1 RT (Meyerhans et al., 1994; Gao et al., 1993) .
Virion-associated HIV-1 DNA synthesis is inhibited after 3Ј-azido-3Ј-deoxythymidine (AZT) treatment of virusproducing cells (Zhang et al., 1996a) . We have also described that the levels of intravirion reverse transcription in blood plasma of HIV-1-infected individuals are altered by treatment with nevirapine, a nonnucleoside analog HIV-1 RT inhibitor, and this phenomenon directly reflects the efficiency and dynamics of the process of intravirion reverse transcription in vivo (Zhang et al., 1996b) . Thus, intravirion HIV-1 DNA synthesis can take place in a physiological microenvironment and is termed "natural endogenous reverse transcription." This process leads to increased infectivity upon initially quiescent target cells and may play a key role in HIV-1 transmission and pathogenesis (Zhang et al., 1996a,b) . Interestingly, our recent data show that the viral core structure of the core envelope-linkage region disappears during the process of intravirion reverse transcription, after incubating the virus with dNTPs and polyamines, and indicates that initiation of reverse transcription occurs in this region of the virion (manuscript submitted).
The major cellular reservoirs for HIV-1 in vivo have been shown to be CD4 ϩ T-lymphocytes and macrophages (Spina et al., 1995; Bukrinsky et al., 1991) . The successful infection of nondividing macrophages or Langerhan cells in the mucosal regions may also be important in sexual transmission of HIV-1 (Miller et al., 1992; Spira et al., 1996) . Of note, the initiation of viral DNA synthesis is efficient in both mature macrophages and quiescent T-lymphocytes, but the kinetics of elongation is delayed (Zack et al., 1990 (Zack et al., , 1992 . After the addition of exogenous nucleosides to cell cultures, RT elongation is increased in macrophages but not in quiescent T-lymphocytes, although this remains controversial (O'Brien et al., 1994; Meyerhans et al., 1994) . Thus, these data from various groups suggest that it is important to investigate whether intravirion reverse transcripts play a role in HIV-1 replication in initially quiescent T-lymphocytes and macrophages. In this report, we have analyzed the levels of intravirion HIV-1 reverse transcripts in virions produced from replicating PBLs compared to those from nonproliferating macrophages and assessed the viral infectivity upon initially quiescent CD4 ϩ T-lymphocytes and nonproliferating macrophages.
RESULTS
Cell-cycle analyses of proliferating (peripheral blood lymphocytes) PBLs and nonreplicating macrophages First, we evaluated replicating PBLs and nonreplicating macrophages via staining with propidium iodide and subsequent flow cytometric analysis. In Fig. 1 , the peaks represent the percentage of cells in each stage of the cell cycle for both PBLs and macrophages, individually. The percentage of quiescent macrophages (G 1 ϩG 0 ) was more than 94%, as indicated in Fig. 1A . Of note, the stimulated PBLs demonstrated proportions of cells throughout the cell cycle (G 1 ϩG 0 , 49%; S, 43.1%; G 2 , 7.9%) (Fig. 1B) . Thus, these initial studies clearly demonstrated that the protocols we utilized led to primarily nonreplicating macrophages and actively proliferating PBLs.
Intravirion HIV-1 reverse transcripts are higher in the virions produced from PBLs than those from macrophages
The levels of intravirion reverse transcripts were estimated in negative-strand strong-stop, gag, U3 regions, and plus-strand regions in the virions from replicating PBLs, as well as nonproliferating macrophages (Fig. 2) . After producing virus from PBLs and macrophages, HIV-1 p24 antigen levels were normalized and captured virions were utilized for DNA-PCR and RT-PCR assays. Of note, virion RNA levels were used, in addition to HIV-1 p24 antigen levels, to strictly normalize virion levels in each preparation. The copy number of intravirion HIV-1 DNA was relatively high in the RU5 region (strong-stop DNA) and then subsequently lower in U3, gag, and RU5-PBS-5NC regions, as described previously (Zhang et al., 1996a) (Fig. 2) . The intravirion HIV-1 DNA levels in the strong-stop negative-strand region (prior to the first template jump) were similar in virions from both PBLs and macrophages. Of note, the U3, gag, and positive-strand copy numbers of intravirion reverse transcripts were significantly higher in viruses derived from PBLs than from macrophages ( Fig. 2 and Table 1 ).
Compared to the virions from untreated replicating PBLs, the virions from AZT-treated, replicating PBLs harbored significantly less intravirion reverse transcripts. This decrease in intravirion reverse transcripts was also noted in virions from AZT-treated macrophages, compared to untreated macrophages. To determine the copy number per virion of intravirion HIV-1 DNA, RNA standard curves were prepared, as described previously (Zhang et al., 1994) . A seperate aliquot of virion:bead complex was used. Viral RNA was extracted and subjected to RT-PCR with the HIV-1 gag primer/probe set and used for analysis of specific cDNA copies of genomic viral RNA in virions produced from each cell type, both with and without AZT treatment ( Fig. 2 and Table 1 ).
Infectivity of PBL-produced virus is greater than macrophage-produced virus
To investigate the infectivity of HIV-1 virus from different cells, we produced NL4-3balenv virus from replicating PBLs and macrophages and treated certain cultures of virus-producing cells with 10 M AZT, prior to harvest of the supernatants. The viruses were placed onto a 20% sucrose-TN solution and pelleted by centrifuging at 90,000 g for 1 h in a Ti60 rotor. The virions were resuspended in RPMI 1640 media and normalized by HIV-1 p24 antigen levels. They were allowed to infect initially quiescent PBLs and macrophages from HIV-1-seronegative individuals at 37°C for 4 h. As illustrated in Fig. 3 , infectivity of HIV-1 virions produced by replicating PBLs were dramatically higher, when compared with the viruses from macrophages, upon initially quiescent PBLs. Of importance, HIV-1 virions produced from replicating PBLs also were more infectious on target macrophages, compared to macrophage-produced virus. After AZT treatment of replicating PBLs and macrophages, the infectivity of virions produced from these cell cultures was decreased, and there was no significant difference in infectivity between those viruses produced from AZTtreated macrophages, compared to those produced from AZT-treated PBLs regardless of the target cell type (Fig.  3) . Of note, the levels of replication of HIV-1 virions from AZT-treated PBLs, on either initially quiescent PBLs or macrophages, were approximately the same as virions produced from macrophages which were not treated with AZT.
Because viral replication was higher in both macrophages and initially quiescent PBLs, with virions produced by replicating PBLs compared to macrophages, it is unlikely that these effects are secondary to differences in cellular proteins on the virion membranes. As well, these studies (Fig. 3) were reproducible using primary
Quantitative analysis of intravirion HIV-1 DNA and RNA levels from PBL-and macrophage-produced virus. HIV-1 virions were captured by anti-gp120 and anti-gp41 antibody-coated latex beads (Abbott) from the supernatants of replicating PBLs and nonproliferating macrophages, followed by DNase treatment. These isolated virions were utilized for DNA-and RT-PCR. Of note, certain cell cultures were treated with AZT, while others were left untreated. After extraction of RNA and DNA, the samples were subjected to PCR with different primer/probe sets (Zhang et al., 1994 (Zhang et al., , 1996a . The viral RNA was extracted and diluted at least 1:100-fold, reverse transcribed into cDNA, and then amplified by PCR (Zhang et al., 1994) . The standard curves were generated using an in vitro transcribed gag RNA fragment or ACH-2 DNA (latently-infected line with one HIV-1 proviral copy per cell) (Zhang et al., 1996a) . The PCR products were analyzed by Southern blot assays and quantitated with a PhosphorImager. (A) Viral RNA; (B) strong-stop negative-strand DNA; (C) U3 DNA; (D) gag DNA; (E) plus-strand DNA (RU5-primer binding site-5NC). 
Virion uptake and internalization
To determine whether the viral infectivity differences demonstrated above were due to differences in virion binding and entry, HIV-1 p24 antigen uptake experiments were performed, as described previously (Zhang et al., 1996a) (Fig. 4) . In brief, the virions produced by replicating PBLs and macrophages, approximately 100 ng of HIV-1 p24 antigen equivalents, were incubated with 10 7 unstimulated PBLs and macrophages at 37°C for 4 h. The unbound virions were washed off with PBS, twice, and the residual bound virions were removed by incubation with 0.25% trypsin (Sigma) for 5 min at 37°C. The trypsin reaction was stopped by washing with serumcontaining medium, and two more washings were performed with PBS. The cells were then analyzed by quantifying intracellular HIV-1 p24 antigen by ELISA (Dupont), after cell lysis. Importantly, there were no significant differences found in the internalization of HIV-1 virions in target cells, either PBLs or macrophages, regardless of producer cell type (Fig. 4) . The viral capacity inside the cell was low when compared to viral input, but HIV-1 p24 antigen levels were approximately the same in both target quiescent PBLs and target macrophages, after thorough washings. Thus, increased binding and internalization of virions was not involved in the increased infectivity of HIV-1 virions produced from replicating PBLs.
DISCUSSION
These studies demonstrate that intravirion reverse transcript levels differ in HIV-1 particles which are produced from nonreplicating human macrophages versus actively proliferating PBLs. Higher levels of intravirion reverse transcripts in HIV-1 virions produced from replicating cells, compared to nonreplicating cells, may be secondary to relatively higher levels of free dNTPs and possibly polyamines in these cells (Zhang et al., 1996a; O'Brien et al., 1994; Collin and Gordon, 1994) . In addition, the present studies demonstrate a direct and distinct correlation between virion infectivity and the cells which produce the virion particles.
We have previously shown that levels of intravirion reverse transcription can be altered without permeabilizing the lentivirion particles (Zhang et al., 1996a) . As such, utilizing physiological substances at relevant concentrations, such as with dNTPs and polyamines, intravirion reverse transcription can be "driven" based on the microenvironment in which the virion particles are localized (Zhang et al., 1996a) . Our previous studies have demonstrated that by stimulating intravirion reverse transcription the infectivity of these lentiviral particles increases in nonproliferating macrophages and initially quiescent PBLs (Zhang et al., 1996a) . This was also clearly demonstrated by other laboratories in nonreplicating neurons in vivo (Naldini et al., 1996) . It is important to note that proliferating T-cells did not show a difference in viral replication between intravirion HIV-1 reverse transcription-stimulated virions and those lacking stimulation of this process (Zhang et al., 1996a) . This was also demonstrated in the present studies, because there was no difference in viral replication in actively replicating PBLs if virions from either macrophages or initially quiescent PBLs were used as a challenge stock (data not illustrated). We have hypothesized that this was due to the differences in intracellular microenvironments which alter the potency of lentiviral reverse transcription after infection of these cells. Clearly, the intracellular environment of nonproliferating macrophages and quiescent PBLs is inhospitable for efficient HIV-1 reverse transcription (Zhang et al., 1996a; O'Brien et al., 1994; Zack et al., 1990 Zack et al., , 1992 Meyerhans et al., 1994) . Thus, those virions with increased intravirion reverse transcripts would have a kinetic advantage in these cell types. This may be why a minority of virions containing increased intravirion reverse transcripts in a viral preparation can alter viral replication in only inhospitable intracellular microenvironments (see reference Zhang et al., 1996a) .
The present studies extend these previous experiments and show that the cell type which produces a virion may alter the virion's infectivity, based on the level of intravirion HIV-1 DNA contained in the produced particles. The same subject's primary cells in an individual experiment were used for both the viral-producing PBLs and macrophages, as well as the PBLs and macrophages used as targets. In this manner, we sought to avoid interactions between virions produced from cells of differing individuals than those cells used as targets. Recent data have demonstrated that HIV-1 virions contain cellular proteins on their surface and, thus, this might be a confounding series of variables if different donors were mixed in each of these separate experiments (Fortin et al., 1997; Arthur et al., 1992) . As well, we repeated these studies in three different HIV-1-seronegative donors to further verify the major findings in these studies, namely that virions from proliferating PBLs are more infectious for both initially quiescent PBLs and macrophages as cell targets.
It remains formally possible that cellular proteins incorporated into virions might also have increased the infectivity of viruses produced from one cell type, when targeted to the same cell type (Fortin et al., 1997; Arthur et al., 1992) . Of note, if this occurred, it did not significantly alter the effects of intravirion reverse transcription which was the leading correlate for increased virion infectivity, whether the same or a different target cell, compared to the producing cell type, was utilized. As noted above, the lack of differences in binding and internalization studies strongly points against cellular protein interactions as a primary cause leading to these findings. Nevertheless, other alterations in the "reverse transcription machinery" of HIV-1 may also occur, with increased intravirion reverse transcripts as a marker for these primary virion changes.
Our laboratories have demonstrated that intravirion reverse transcription also alters simian immunodeficiency virus (SIV) infectivity (Dornadula et al., 1997) . In recent studies these initial findings were extended in an in vivo macaque model system. Intravenous infection of monkeys with SIV virion preparations, in which intravirion reverse transcription was stimulated, led to increased viral replication and longer time periods of detectable virus in the bloodstream of macaques, compared to macaques infected with normalized virion preparations in which intravirion reverse transcription was not stimulated (manuscript submitted). Thus, intravirion reverse transcription may be critical in altering viral infectivity levels in primate lentiviruses and may also be important in molecular mechanisms involved with vertical and/or horizontal transmission of primate lentiviruses.
The present studies suggest that HIV-1 virions from actively replicating CD4 ϩ T-lymphocytes may have increased infectivity during inter-or intrahost transmission, compared to virions produced from nonreplicating, tissue-bound macrophages. Of note, the precise cells infected in the female genital tract by primate lentiviruses remain somewhat controversial (Miller et al., 1992 (Miller et al., , 1998 Spira et al., 1996) . As such, further studies will be useful in further determining the in vivo importance of these findings for understanding HIV-1 and SIV/HIV-2 transmission and pathogenesis.
MATERIALS AND METHODS

Virus
The envelope (env) gene of the T-cell-line-tropic (CXCR-4-tropic) HIV-1 strain, NL4-3, was replaced with that of the macrophage-tropic (CCR5-tropic) HIV-1 Bal strain by removing a SalI-BamHI fragment of the R8 Bal plasmid (kindly provided by Dr. D. Trono, University of Geneva) and placing it in the same site in NL4-3. The new plasmid was sequence-confirmed and titled pNL4-3balenv, which now had macrophage-tropic properties. To generate a viral stock, 10 g of pNL4-3balenv plasmid DNA was transfected into RD (rabdomyosarcoma) cells by calcium phosphate precipitation (Zhang et al., 1995a) . The supernatant was harvested on day 5 and stored in aliquots at Ϫ70°C.
Cells and production of HIV-1 virions
Peripheral blood mononuclear cells were derived from healthy, HIV-1-seronegative normal donors by Ficoll gradient centrifugation. The isolated PBMCs were placed onto 2% gelatin-coated flasks to isolate monocyte/macrophages (Collman et al., 1989) . The unattached PBLs were washed with phosphate-buffered saline (PBS) twice and cultured for 48 h, in either the presence or the absence of purified phytohemagglutinin (PHA) (Sigma) (10 g/ml) and 50 units of natural human interleukin II (IL-2; BRL-GIBCO). The attached monocyte/macrophages were resuspended with 5 mM EDTA and cultured in a mixture of 10% fetal calf serum (FCS), 10% horse serum, and 0.1 mM nonessential amino acids (NEAA) (GIBCO) for 14 days, as described previously (Collman et al., 1989) . The replicating PBLs and nonreplicating macrophages were then infected with the NL4-3balenv stock virus. The unbound virions were washed off vigorously with PBS. After 5 days, the supernatants harboring progeny viruses were collected and frozen at Ϫ70°C. As controls, specific cultures of PBLs and macrophages were treated with 10 M of AZT (Sigma) and allowed to grow for a further 3 days. The supernatants were collected and passed through a 20% sucrose cushion to remove the AZT. Control virion-containing supernatants (without AZT) were also passed through a 20% sucrose cushion at the same time. Then, the virion preparations were normalized by quantitating for HIV-1 p24 antigen via enzyme-linked immunosorbant assays (ELISA; Dupont) and used in infectivity assays. All experiments were performed in primary cells from HIV-1-seronegative individuals and repeated using three different individuals' cells, in independent studies.
Cell-cycle analyses
To estimate the percentage of replicating PBLs and nonproliferating macrophages in each stage of the cell cycle, the cells were prepared for fluorescence-activated cell sorting analysis. Briefly, 0.5 ϫ 10 6 cells were mixed gently with 70% ethanol and incubated on ice for 10 min. Then, the cells were concentrated and resuspended in 100 l of RNase A (180 g/ml) and incubated for 30 min at room temperature. After addition of 200 l of propidium iodide (50 g/ml; Sigma), the cells were incubated for 15 min at room temperature and analyzed by flow cytometry (Becton Dickinson).
Intravirion HIV-1 reverse transcripts
For analysis of intravirion reverse transcripts, the virions were isolated by an immunocapture methodology. HIV-1 virions produced from AZT-treated or nontreated cells were captured by anti-gp120 and anti-gp41 coated beads (Abbott, Inc.) from the supernatants of replicating PBLs and nonreplicating macrophages producing virus. After DNase treatment, as described previously (Zhang et al., 1994) , quantitative DNA-and RT-PCR were performed. The RU5 region (negative-strand, strong-stop DNA) was detected with primer/probe set, M667-AA55/ SK31; the gag region was detected by primer/probe set, SK38-SK39/SK19. The U3 region was detected by the primer pair U31-U32/probe U33, and the RU5-primer binding site-5Ј noncoding region (5NC), which amplifies nearly full-length reverse transcripts, was detected by the primer/probe set, M667-M661/SK31 (Zhang et al., 1994) . The PCR products were analyzed by standard Southern blotting. The 32 P-labeled blots were analyzed and quantitated with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) and copy numbers were calculated by comparison with standard curves (Zhang et al., 1994) . RT-PCR for HIV-1 RNA in virions was performed using the gag primer and probe set, as described previously (Zhang et al., 1994) .
Viral infectivity
The viral infectivity assays were performed with viruses produced from stimulated PBLs and macrophages, by incubation with initially unstimulated PBLs and macrophages at 37°C for 4 h. The input of virions was strictly normalized in all infections (500 pg of HIV-1 p24 antigen). The unbound virions were washed off with PBS, three times, and PBLs were cultured in RPMI 1640 medium plus 10% FCS and the macrophages were cultured in Dulbecco's modified Eagle's medium plus 10% FCS, 10% horse serum, and 0.1 mm NEAA. After overnight incubation, supernatants were collected on day 0 for HIV-1 p24 antigen detection via ELISA. On the third day postinfec-tion, PHA (5 g/ml; Sigma) and natural human IL-2 (50 U/ml; BRL-GIBCO) were added to the PBL cultures. On the fifth day, PHA and IL-2 were washed off by pelleting the infected cells via centrifugation. The PBLs were then cultured with IL-2 (10 U/ml) only. Samples of the supernatants (0.5 ml each) were collected at specified time points. The HIV-1 p24 antigen levels were quantitated by ELISA. Of importance, the same individuals' cells were used to produce virions and as target cells.
